Clinical significance of serum vascular endothelial growth factor in young male asthma patients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis. However, little is known about the potential use of serum levels of VEGF as a biomarker for asthma. We investigated the differences in VEGF levels among normal controls, stable asthma patients, and those with exacerbation of acute asthma. All subjects were young males. Methods: We measured VEGF levels in each patient group, and examined any serial changes in those with acute exacerbation. Results: VEGF levels were significantly higher in stable asthmatic patients and even more so in acute asthmatic patients, compared to healthy controls. However, there was no correlation between VEGF levels and forced expiratory volume in 1 second in patients with stable asthma. In addition, there were no correlations between VEGF levels and asthma control test scores. In patients with acute exacerbation, VEGF levels significantly increased during the acute period; their levels decreased gradually at 7 and 14 days after treatment. Conclusions: Compared to normal control patients, the serum levels of VEGF were elevated in stable asthma patients and even more elevated in patients with acute exacerbation. However, the role of VEGF as a biomarker in stable asthma is limited. In patients with acute exacerbation, VEGF levels were associated with clinical improvements.
Abstract
Background/Aims: Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis. However, little is known about the potential use of serum levels of VEGF as a biomarker for asthma. We investigated the differences in VEGF levels among normal controls, stable asthma patients, and those with exacerbation of acute asthma. All subjects were young males. Methods: We measured VEGF levels in each patient group, and examined any serial changes in those with acute exacerbation. Results: VEGF levels were significantly higher in stable asthmatic patients and even more so in acute asthmatic patients, compared to healthy controls. However, there was no correlation between VEGF levels and forced expiratory volume in 1 second in patients with stable asthma. In addition, there were no correlations between VEGF levels and asthma control test scores. In patients with acute exacerbation, VEGF levels significantly increased during the acute period; their levels decreased gradually at 7 and 14 days after treatment. Conclusions: Compared to normal control patients, the serum levels of VEGF were elevated in stable asthma patients and even more elevated in patients with acute exacerbation. However, the role of VEGF as a biomarker in stable asthma is limited. In patients with acute exacerbation, VEGF levels were associated with clinical improvements.
참고문헌 (29)
- Bara I, "Pathophysiology of bronchial smooth muscle remodelling in asthma", Eur Respir J, 36, pp.1174~1184 (2010)
- Li X, "Increased vascularity of the bronchial mucosa in mild asthma", Am J Respir Crit Care Med, 156, pp.229~233 (1997)
- Wilson J., "The bronchial microcirculation in asthma", Clin Exp Allergy, 30(Suppl 1), pp.51~53 (2000)
- Zanini A, "The role of the bronchial microvasculature in the airway remodelling in asthma and COPD", Respir Res, 11, pp.132~ (2010)
- Bergeron C, "Airway remodelling in asthma: from benchside to clinical practice", Can Respir J, 17, pp.e85~e93 (2010)
- Hoshino M, "Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis", J Allergy Clin Immunol, 107, pp.295~301 (2001)
- Detoraki A, "Angiogenesis and lymphangiogenesis in bronchial asthma", Allergy, 65, pp.946~958 (2010)
- Ribatti D., "The crucial role of vascular permeability factor", vascular endothelial growth factor in angiogenesis: a historical review, 2005, pp.128, 303~309
- Mura M, "Vascular endothelial growth factor and related molecules in acute lung injury", J Appl Physiol (1985), 97, pp.1605~1617 (2004)
- Lee CG, "Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung", Nat Med, 10, pp.1095~1103 (2004)
- Wen FQ, "TH2 cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids", J Allergy Clin Immunol, 111, pp.1307~1318 (2003)
- Bateman ED, "Global strategy for asthma management and prevention: GINA executive summary", Eur Respir J, 31, pp.143~178 (2008)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Wanger J, "Standardisation of the measurement of lung volumes", Eur Respir J, 26, pp.511~522 (2005)
- Kanazawa H, "Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients", Thorax, 57, pp.885~888 (2002)
- Asai K, "Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects", J Allergy Clin Immunol, 110, pp.571~575 (2002)
- Asai K, "Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients", Clin Exp Allergy, 33, pp.595~599 (2003)
- Papadaki G, "Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma", Respir Med, 107, pp.1339~1345 (2013)
- Abdel-Rahman AM, "A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack", Chest, 129, pp.266~271 (2006)
- Feltis BN, "Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma", Am J Respir Crit Care Med, 173, pp.1201~1207 (2006)
- Zou H, "Analysis of growth factors in serum and induced sputum from patients with asthma", Exp Ther Med, 8, pp.573~578 (2014)
- Bikov A, "Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy", Biomarkers, 17, pp.648~654 (2012)
- Lee KY, "Clinical significance of plasma and serum vascular endothelial growth factor in asthma", J Asthma, 45, pp.735~739 (2008)
- Meyer N, "Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways", Curr Allergy Asthma Rep, 13, pp.1~9 (2013)
- Farid Hosseini R, "Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease", Med J Islam Repub Iran, 28, pp.85~ (2014)
- Zampeli E, "Increased expression of VEGF, COX-2, and Ki-67 in Barrett’s esophagus: does the length matter?", Dig Dis Sci, 57, pp.1190~1196 (2012)
- Lee CG, "Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease", Proc Am Thorac Soc, 8, pp.512~515 (2011)
- Kanazawa H, "Role of vascular endothelial growth factor in pulmonary endothelial cell injury by exercise challenge in asthmatic patients", J Asthma, 43, pp.267~271 (2006)
- Kanazawa H., "Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implication of vascular endothelial growth factor", Inflamm Allergy Drug Targets, 6, pp.133~137 (2007)